CenExel Clinical Research, a steadily growing national clinical research firm based out of Salt Lake City, strengthened its psychiatric team with by signing on Mark N. Lerman, MD, to join as a principal investigator for Phase I-IV studies at the Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence. ACMR has established itself as a leader in clinical research with a focus on central nervous disorder-based studies. Dr. Lerman joins three other principal investigators and six sub-investigators, each with decades of experience.
CenExel now continues to add to its deepening team of physician investigators with specialized focus on psychiatry with a team including Robert A. Riesenberg, MD, Mahendra Dave, MD and Mark N. Lerman, MD. With over 40 years of experience spanning more than 1,700 studies, Dr. Riesenberg is ACMR’s medical director and serves on the CenExel Psychiatric Advisory Board. Dr. Dave, Distinguished Fellow of the American Psychiatric Association, has over 20 years of clinical trial experience, and has been the lead author of several industry books, including Laboratory values in Psychiatry Clinical Trials. Dr. Lerman has more than 25 years of experience, almost entirely in psychiatric medical research, conducting over 300 studies. He also joined CenExel’s Psychiatric Advisory Board.
ACMR enjoys the largest facility of its kind for private research, specializing in recruiting pediatric, adult, and geriatric psychiatric studies. ACMR also relies on unique facility perks to provide a reliable and consistent psychiatric clinical trial experience.
Call to Action: Interested in learning more? Contact CenExel at media@CenexelResearch.comSource: HJ News